Buscar
Conmed Corp
CNMDAñadir a la lista de seguimiento
46.300USD
-0.670-1.43%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
1.39BCap. mercado
26.11P/E TTM
Más Datos de Conmed Corp Compañía
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Información de Conmed Corp
Símbolo de cotizaciónCNMD
Nombre de la empresaConmed Corp
Fecha de salida a bolsaJul 23, 1987
Director ejecutivoBeyer (Patrick J)
Número de empleados3900
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 23
Dirección11311 Concept Boulevard
CiudadLARGO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal33773
Teléfono17272142974
Sitio Webhttps://www.conmed.com/
Símbolo de cotizaciónCNMD
Fecha de salida a bolsaJul 23, 1987
Director ejecutivoBeyer (Patrick J)
Ejecutivos de Conmed Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.91K
+3.73%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
--
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
6.45K
+10.35%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
--
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.04K
-8.65%
Mr. Charles (Chuck) Farkas
Mr. Charles (Chuck) Farkas
Independent Director
Independent Director
--
--
Ms. Johonna Marie Pelletier
Ms. Johonna Marie Pelletier
Treasurer and Vice President - Tax
Treasurer and Vice President - Tax
--
--
Mr. Todd W. Garner
Mr. Todd W. Garner
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.91K
+3.73%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
--
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
6.45K
+10.35%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
--
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Conmed Corp?
Los cinco principales accionistas de Conmed Corp son: Mr. David M. Bronson
¿Cuántas instituciones poseen acciones de Conmed Corp (CNMD)?
A fecha de 2026Q1, 638 instituciones poseen acciones de Conmed Corp, con un valor de mercado combinado de aproximadamente 34.51M, lo que representa el 114.61% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -7041128.00.
¿Cuál es la mayor fuente de ganancias de Conmed Corp?
El 2026Q1, el segmento empresarial General Surgery generó la ganancia más alta para Conmed Corp, ascendiendo a 800.13M y representando el 58.20% de la ganancia total.